Investing.com - Cannabis stock Tilray continued its winning streak midday, but other major marijuana stocks were snubbed as investors grappled with valuations in the young sector.
Meanwhile, Turkish American Depositary Receipts (ADRs) surged after a surprisingly high interest-rate boost from the country’s central bank.
Tilray (NASDAQ:TLRY) rose about 12% at 11:55 AM ET (15:55 GMT).
The stock is still in favor despite a run that’s seen shares climb more than 300% since its July IPO and recent negative comments from short-seller Citron.
But there is consternation in a sector that has seen such a big run-up as investors look at fundamentals.
“You might argue our valuations are a little bit ahead of our skis,” Paul Rosen, chief executive officer of Tidal Royalty, which finances weed companies, told Bloomberg Wednesday.
Concerns about a U.S. Food and Drug Administration crackdown on vaping has also raised questions about what that means for the sector.
Canopy Growth (NYSE:CGC) fell about 3%, while Cronos Group (NASDAQ:CRON) dropped about 4% and Aurora Cannabis (OTC:ACBFF) was off about 3%.
Elsewhere, Turkish stocks traded in the U.S. climbed sharply after the country's central bank boosted the one-week repo rate by 625 basis points to 24%, sending the lira, USD/TRY, higher.
That naturally helped bank stocks like Turkiye Garanti Bankasi (OTC:TKGBY), which gained about 8%, and Akbank (OTC:AKBTY), up about 7%.
Turkish telecoms, which had been hit by the weakness in the lira, were also strong.
Turkcell (NYSE:TKC) jumped about 9% and Turk Telekomunikasyon (OTC:TRKNY) rallied up about 10%.